Elevated albumin excretion in nonmodulating essential hypertensive patients

Nephron

Volumn 76, Issue 3, 1997, Pages 264-269

  Baldoncini, Roberta ^a   Bellini, Cesare ^b   Desideri, Giovambattista ^a   De Angelis, Claudio ^b   Ferri, Claudio ^a   Santucci, Anna ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Albumin; Hypertension; Lipids; Salt

Indexed keywords

ALBUMIN; ALDOSTERONE; ANGIOTENSIN; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITROGEN; RENIN; UREA;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; UREA NITROGEN BLOOD LEVEL; URINE LEVEL;

EID: 0030792283     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000190190     Document Type: Article

References (36)

1. Parving HH, Oxenholl B, Svcndsen PA, Christiansen JS, Andersen AR: Early detection of patients at risk of developing diabetic nephropathy: A longitudinal study of urinary albumin excretion, Acta Endocrinol 1982; 100:550-555.
2. Mogenscn CE, Christensen CK: Predicting diabetic nephropathy in insulin-dependent patients, N Engl J Med 1984;311:89-93.
3. Viberti GC, Hill RD, Jarrett RJ, Argyropoulos A, Mahmud U, Keen H: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus, Lancet 1982;i: 1430-1432.
4. Jarrett RJ, Viberti GC, Argyropoulos A, Hill RD, Mahmud U, Murrells TJ: Microalbuminuria predicts mortality in non-insulin-dependent diabetes, Diabel Med 1984; 1:17-19.
5. Mogensen CE: Microalbuminuriapredictsclin-ical proteinuria and early mortality in maturi-ty-onsct diabetes, N Engl J Med 1986:310:356-360.
6. Yudkin JS, Forrest RD, Jackson CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects, Lancet 1988:3:530-533.
7. Giaconi S, Levanti C, Fommei E, Innocenti F, Seghieri G, Palla L, Palombo C, Ghione S: Microalbuminuria and casual and ambulatory blood pressure monitoring in normotensives and in patients with borderline and mild essential hypertension, Am J Hypertens 1989;2: 259-261.
8. Bianchi S, Bigazzi R, Baldari G, Campese VM: Prevalence of microalbuminuria in a large population of patients with essential hypertension, Nephron 1992:61:94-97.
9. Mogensen CE, Christensen CK, Christensen NJ, Gundersen HJG, Jacobsen FK, Pedersen EB, Vittinghus E: Renal protein handling in normal hypertensive and diabetic man, Con-trib Nephrol, Basel, Karger, 1981. vol 24. pp 139-152.
10. Parsing HH, Jensen HE, Mogensen CE, Evrin PE: Increased urinary albumin excretion in benign essential hypertension, Lancet 1974;1: 231-237.
11. Bigazzi R, Bianchi S, Baldari D, Sgherri G, Baldari G, Campese VM: Microalbuminuria in salt-sensitive patients, A marker for renal and cardiovascular risk factors, Hypertension 1994:23:195-199.
12. Ferri C, Bellini C, Coassin S, Baldoncini R, Perronc A, Santucci A: Abnormal renal and atrial natriuretic peptide responses to saline infusion in nonmodulating essential hypertension, Circulation 1994;90:2859-2869.
13. Hollcnberg NK, Williams GH: Abnormal renal function, sodium-volumc homeostasis, and renin system behavior in normal-rcnin essential hypertension: in Laragh JH, Brenner BM (eds): Hypertension: Pathophysiology, Diagnosis, and Management, New York, Raven Press, 1990. pp 1349-1370.
14. Leonetti Luparini R, Ferri C, Santueei A, Bal-sano F: Atrial natriuretic peptide in non-modulating essential hypertension, Hypertension 1993:21:803-809.
15. Friedcwald WT, Levy R, Fredrickson DS: Estimation of the concentration of low-dcnsity lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge, Clin Chem 1972;18:499-502.
16. Watts GF, Bennett JE, Rowe DJ, Gatling W, Shaw KM, Polak A: Assessment of immunochemical methods for determining low concentrations of albumin in urine, Clin Chem 1986; 32:1544-1548.
17. Silver A, Dawnay A, Landon J, Catteli WR: Immunoassays for low concentrations of albumin in urine, Clin Chem 1986:32:1303-1306.
18. Overlack A, Ruppert M, Kolloch R, Gobcl B, Kraft K, Diehl J, Schmitt W, Stumpe KO: Divergent hemodynamic and hormonal responses to varying salt intake in normotensive subjects, Hypertension 1993;22:331-338.
19. Redgrave J, Canessa M, Gleason R, Hollenberg NK, Williams GH: Red blood cell lithium-sodium countertransport in non-modulating hypertension, Hypertension 1989:13:721-726.
20. Hoegholm A, Bang LE, Kristenscn KS, Nielsen JW, Holm J: Microalbuminuria in 411 untreated individuals with established hypertension, white coat hypertension, and normoten-sion, Hypertension 1994;24:101-105.
21. Ljungman S, Wikstrand J, Hartford M, Aurell M, Lindstedt G, Berglund G: Effects of longterm antihypertensive treatment and aging on renal function and albumin excretion in primary hypertension, Am J Hypertens 1993:6:554-563.
22. Williams GH, Hollenberg NK: Non-modulating hypertension: A subset of sodium-sensitive hypertension, Hypertension 1991; 17(suppl I): 81-85.
23. Rystedt LL, Williams GH, Hollenberg GH: Renal and endocrine response to saline infusion in essential hypertension, Hypertension 1986:8: 217-222.
24. Pedrinelli R, Giampictro O, Carmassi F, Melil-lo E, Dell’Omo G, Catapano G, Matlcucci E, Talarico L, Morale M, De Negri F, Di Bello V: Microalbuminuria and endothelial dysfunction in essential hypertension, Lancet 1994:344:14-18.
25. Samuclsson O, Wilhclmsen L, Elmfeldl D, Pennert K, Wedel H, Wilkstrand J, Berglund G: Predictors of cardiovascular morbidity in treated hypertension results from the primary preventive trial in Goteborg, Sweden, J Hypertens 1985:3:167-176.
26. Bulpitt CJ, Bcevers DG, Butler A, Coles EC, Hunt D, Munro-Faure AD, Newson RB, O'Riordan PW, Petrie JC, Rajagopalan B, Rylance PB, Twallin G, Webster J, Dollery CT: The survival of treated hypertensive patients and their causes of death: A report from the DHSS Hypertensive Care Computing Project (DHCCP), J Hypertens 1986;4:93-99.
27. Pederson EB, Mogensen CE: Effect of antihypertensive treatment on urinary albumin excretion, glomerular filtration rate, and plasma flow in patients with essential hypertension, Scand J Clin Lab Invest 1976:36:231-237.
28. Samuelsson O: Proteinuria as a prognostic factor during long-term hypertensive care, Drugs 1988:35(suppl 5):48-54.
29. Nosadini R, Semplicini A, Fioretto P, Lusiani L, Trevisan R, Donadon V, Zanette G, Nocolo-si GL, Dall'Aglio V, Zanuttini D, Viberti GC: Sodium-lithium countcrtransport and cardiorenal abnormalities in essential hypertension, Hypertension 1991;8:191-198.
30. Mendez A, Perez GO, Goldberg RB, Hsia SL: Lipid and lipoprotein levels in undialyzed patients with chronic renal failure, Am J Med Sci 1987;293:164-165.
31. Attman PO, Alaupovic P, Gustafson A: Serum apolipoprotein profile of patients with chronic renal failure, Kidney lnt 1987:32:368.
32. Jenkins AJ, Steel JS, Janus ED, Best JD: Increased plasma apoprotein (a) levels in IDDM patients with microalbuminuria, Diabetes 1991;40:787-790.
33. Kapelrud H, Bangstad HJ, Dahl-Jorgensen K, Berb K, Hanssen KF: Serum I, p(a) lipoprotein concentrations in insulin-dependent diabetic patients with microalbuminuria, Br Med J 1991:303:675-678.
34. Keane WF, Peter J VS, Kasiske BL: Is the aggre-sive management of hyperlipidemia in nephrotic syndrome mandatory? Kidney Int 1992;42(sitppl 38): 134-141.
35. Kaysen GA: Hyperlipidemia of the nephrotic syndrome, Kidney Int 1991;39(suppl 31):8-15.
36. Newmark SR, Anderson CF, Donadio JV, El-lefscn RD: Lipoprotein profiles in adult ne-phrotics, Mayo Clin Proc 1975;50:359-366.